Readystate Asset Management’s Gilead Sciences GILD Stock Holding History

Readystate Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$376K	Buy	+2,700	New	+$378K	0.02%	669
2025 Q2	–	Sell	-33,300	Closed	-$3.73M	–	730
2025 Q1	$3.73M	Sell	33,300 -10,600	-24%	-$1.09M	0.12%	138
2024 Q4	$4.06M	Sell	43,900 -40,700	-48%	-$3.66M	0.12%	171
2024 Q3	$7.09M	Buy	+84,600	New	+$6.46M	0.13%	267
2024 Q2	–	Sell	-21,600	Closed	-$1.58M	–	877
2024 Q1	$1.58M	Sell	21,600 -21,100	-49%	-$1.62M	0.02%	617
2023 Q4	$3.46M	Buy	42,700 +39,700	+1,323%	+$3.09M	0.12%	182
2023 Q3	$225K	Hold	3,000	–	–	0.01%	484
2023 Q2	$231K	Sell	3,000 -1,000	-25%	-$79.8K	0.02%	261
2023 Q1	$332K	Buy	+4,000	New	+$331K	0.03%	187

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Readystate Asset Management's GILD Position: Q2 2025 in Review

Readystate Asset Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 5,797 shares — an estimated $650K sold.

Readystate Asset Management first reported a position in GILD in Q4 2023 and held it in 3 quarters. The position peaked at $650K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

Readystate Asset Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
Readystate Asset Management sold 5,797 Gilead Sciences shares in Q2 2025, an estimated $650K.
Readystate Asset Management first reported a position in Gilead Sciences in Q4 2023 and held it in 3 quarters.
Readystate Asset Management's Gilead Sciences position peaked at $650K in Q1 2025.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.